MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs

Chung-Pu Wu, Sabrina Lusvarghi, Pin-Jung Tseng, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung, Suresh V Ambudkar

Research output: Contribution to journal › Journal Article › peer-review

Fingerprint

Dive into the research topics of 'MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology